BFM
CMMB

Boothbay Fund Management’s Chemomab Therapeutics CMMB Stock Holding History

Boothbay Fund Management’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,547
Closed -$30.4K – 1897
2025
Q2 		$30.4K Hold
6,547
– – ﹤0.01% 1378
2025
Q1 		$28.5K Hold
6,547
– – ﹤0.01% 1315
2024
Q4 		$47.4K Sell
6,547
-85
-1% -$537 ﹤0.01% 1361
2024
Q3 		$41.7K Hold
6,632
– – ﹤0.01% 1519
2024
Q2 		$24.2K Hold
6,632
– – ﹤0.01% 1448
2024
Q1 		$20.7K Hold
6,632
– – ﹤0.01% 1505
2023
Q4 		$13.5K Hold
6,632
– – ﹤0.01% 1596
2023
Q3 		$23.7K Hold
6,632
– – ﹤0.01% 1658
2023
Q2 		$34.9K Hold
6,632
– – ﹤0.01% 1693
2023
Q1 		$42.2K Sell
6,632
-6,270
-49% -$49.2K ﹤0.01% 2031
2022
Q4 		$165K Buy
12,902
+3,559
+38% +$30.7K ﹤0.01% 1664
2022
Q3 		$93K Sell
9,343
-982
-10% -$12.7K ﹤0.01% 2057
2022
Q2 		$153K Hold
10,325
– – ﹤0.01% 1862
2022
Q1 		$198K Buy
10,325
+3,162
+44% +$62.3K ﹤0.01% 1887
2021
Q4 		$198K Sell
7,163
-3,702
-34% -$131K ﹤0.01% 1496
2021
Q3 		$482K Sell
10,865
-2,817
-21% -$171K 0.01% 1107
2021
Q2 		$1.04M Sell
13,682
-1,758
-11% -$172K 0.03% 664
2021
Q1 		$1.77M Buy
+15,440
New +$3.07M 0.07% 363

Other funds holding CMMB

SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Boothbay Fund Management's CMMB Position: Q3 2025 in Review

Boothbay Fund Management sold out of Chemomab Therapeutics (CMMB) in Q3 2025, closing a stake of 6,547 shares — an estimated $30.4K sold.

Boothbay Fund Management first reported a position in CMMB in Q1 2021 and held it in 18 quarters. The position peaked at $1.77M in Q1 2021. 10 funds tracked by Wall St. Rank hold CMMB as of Q3 2025.

  • Boothbay Fund Management reported no remaining Chemomab Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 6,547 Chemomab Therapeutics shares in Q3 2025, an estimated $30.4K.
  • Boothbay Fund Management first reported a position in Chemomab Therapeutics in Q1 2021 and held it in 18 quarters.
  • Boothbay Fund Management's Chemomab Therapeutics position peaked at $1.77M in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.